Delivery Order SPE2DB20D2014-SPE2DB25FA44L
Award Date
11/26/24
Potential Completion Date
11/27/24
Potential Value
$7.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,612.40 firm fixed price delivery order is for the period through August 26, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $1,417.47, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of April 28, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The $8,708.10 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of July 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of Ozempic, a 1 mg/dose pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The firm-fixed-price delivery order, valued at $10,313.39, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 24, 2024. The contract has an ultimate completion date of October 25, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The $1,741.62 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of April 29, 2024. This is a delivery order placed against Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp's Corporate Office Division. The contract has a ceiling value of $6,774.52 and runs through June 25, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a range of...
This federal contract award is for the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, awarded by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The $1,659.81 firm fixed-price delivery order has a performance period through May 8, 2023. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to...
The federal contract award is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,161.08, is a firm fixed-price delivery order placed by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of August 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of Ozempic 2mg/dose (8mg/3mL) 3mL, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $77,430.83 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 11, 2024 with a completion date of December 12, 2024. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication to the Defense Logistics Agency (DLA). The $4,350.63 firm-fixed-price delivery order has a completion date of December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including...